Profile
Jason Paragas is currently the Chief Executive Officer at DVLP Medicines.
He is also a Director at Probius DX, Inc. and a Venture Partner at Social Impact Capital, Inc. Mr. Paragas holds a doctorate degree from Icahn School of Medicine at Mount Sinai, which he obtained in 2001.
Jason Paragas active positions
| Companies | Position | Start |
|---|---|---|
Probius DX, Inc.
 Probius DX, Inc. Medical SpecialtiesHealth Technology ProbiusDx, Inc. develops devices that analyses multiple target proteins. The company was founded by Roger T. Howe, Chaitanya Gupta and Emmanuel P. Quevy and is headquartered in El Cerrito, CA. | Director/Board Member | - |
Social Impact Capital, Inc.
 Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Private Equity Investor | 01/04/2021 |
Training of Jason Paragas
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Probius DX, Inc.
Probius DX, Inc. Medical SpecialtiesHealth Technology ProbiusDx, Inc. develops devices that analyses multiple target proteins. The company was founded by Roger T. Howe, Chaitanya Gupta and Emmanuel P. Quevy and is headquartered in El Cerrito, CA. | Health Technology |
Social Impact Capital, Inc.
Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Finance |
- Stock Market
- Insiders
- Jason Paragas
